In a previous preclinical study, radiotherapy up‐regulated the cell surface expression of programmed cell death ligand 1 (PD‐L1) in bladder cancer cells, in whose immune microenvironment PD‐L1 blockade may be more effective.19 This evidence concerns the gene CD274 and urinary bladder carcinoma.